Associating the risk of three urinary cancers with obesity and overweight: an overview with evidence mapping of systematic reviews
- PMID: 33597037
- PMCID: PMC7888186
- DOI: 10.1186/s13643-021-01606-8
Associating the risk of three urinary cancers with obesity and overweight: an overview with evidence mapping of systematic reviews
Abstract
Background: The relationship between cancer with overweight and obesity has been extensively reported. However, the association between urinary cancers with these risk factors remains unclear, with existing reports showing conflicting findings. The current review, therefore, sought to clarify the latter association by assessing the methodological and reporting quality of existing systematic reviews on the subject.
Methods: We first screened PubMed, EMBASE, and Cochrane Library databases for relevant literature and subjected the resulting articles to meta-analysis. We adopted the AMSTAR-2 and PRISMA checklists for assessing methodological and reporting quality, respectively, then performed meta-analyses to determine the relationship between incidence and mortality of three types of urinary cancers with obesity and overweight. Indirect comparisons were also done across subgroups.
Results: All systematic reviews (SRs) were of critically low methodological quality. Seventeen SRs had minimal reporting flaws, and 11 SRs had minor reporting flaws. We found an association between obesity with an incidence of kidney (RR = 1.68, 95% CI 1.47-1.92), bladder (RR = 1.1, 95% CI 1.07-1.13), and prostate (RR = 1.02, 95% CI 0.91, 1.13) cancers. Similarly, overweight was associated with the incidence of the three types of cancer, recording RR values of 1.37 (95% CI 1.26-1.48), 1.07 (95% CI 1.03-1.1), and 1 (95% CI 0.93, 1.07) for kidney, bladder, and prostate cancers, respectively. With regard to the dose analysis, the RR of BMI (per 5 kg/m2 increase) was associated with kidney (RR = 1.24, 95% CI 1.2-1.28), bladder (RR = 1.03, 95% CI 1.02-1.05), and prostate (RR = 1.02, 95% CI 1.01, 1.03) cancers.
Conclusions: This comprehensive quantitative analysis provides an affirmation that overweight and obesity are strong risk factors for kidney cancer, owing to a strong association between them. Conversely, a weak association between overweight and obesity with bladder and prostate cancers confirms their status as mild risk factors for the 2 types of cancer. But due to the low quality of included SRs, the results need to be interpreted with caution.
Systematic review registration: PROSPERO CRD42019119459.
Keywords: Cancer; Meta-analysis; Obesity; Overweight.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
Similar articles
-
The association between body mass index and the risk of different urinary cancers: Protocol for an overview of systematic reviews.Medicine (Baltimore). 2020 Jul 24;99(30):e21362. doi: 10.1097/MD.0000000000021362. Medicine (Baltimore). 2020. PMID: 32791741 Free PMC article.
-
Reporting and Methodological Quality of Systematic Reviews and Meta-Analyses of Nursing Interventions in Patients With Alzheimer's Disease: General Implications of the Findings.J Nurs Scholarsh. 2019 May;51(3):308-316. doi: 10.1111/jnu.12462. Epub 2019 Feb 25. J Nurs Scholarsh. 2019. PMID: 30806019
-
Association of overweight/obesity and digestive system cancers: A meta-analysis and trial sequential analysis of prospective cohort studies.PLoS One. 2025 Apr 1;20(4):e0318256. doi: 10.1371/journal.pone.0318256. eCollection 2025. PLoS One. 2025. PMID: 40168281 Free PMC article.
-
Effectiveness and safety of manual therapy for knee osteoarthritis: An overview of systematic reviews and meta-analyses.Front Public Health. 2023 Feb 24;11:1081238. doi: 10.3389/fpubh.2023.1081238. eCollection 2023. Front Public Health. 2023. PMID: 36908468 Free PMC article.
-
Anthropometric factors and the risk of ovarian cancer: A systematic review and meta-analysis.Cancer Rep (Hoboken). 2022 Nov;5(11):e1618. doi: 10.1002/cnr2.1618. Epub 2022 Apr 5. Cancer Rep (Hoboken). 2022. PMID: 35384414 Free PMC article.
Cited by
-
Navigating the obesity paradox in bladder cancer prognosis-insights from the Taiwan National Health Insurance System Database.Front Nutr. 2024 Dec 11;11:1433632. doi: 10.3389/fnut.2024.1433632. eCollection 2024. Front Nutr. 2024. PMID: 39723162 Free PMC article.
-
Developing Family-Community Interactive program for the disabled older adults at home: a study protocol.BMC Geriatr. 2023 Sep 29;23(1):609. doi: 10.1186/s12877-023-04273-7. BMC Geriatr. 2023. PMID: 37773100 Free PMC article.
-
2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery.Obes Surg. 2023 Jan;33(1):3-14. doi: 10.1007/s11695-022-06332-1. Obes Surg. 2023. PMID: 36336720 Free PMC article.
-
A qualitative study of the interaction experiences between family caregivers and community nurses for disabled elderly people at home.BMC Geriatr. 2023 Apr 21;23(1):243. doi: 10.1186/s12877-023-03917-y. BMC Geriatr. 2023. PMID: 37085787 Free PMC article.
-
Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts.Br J Cancer. 2024 Feb;130(2):308-316. doi: 10.1038/s41416-023-02526-1. Epub 2023 Dec 12. Br J Cancer. 2024. PMID: 38087039 Free PMC article.
References
-
- Al-Othman S, Haoudi A, Alhomoud S, et al. Tackling cancer control in the Gulf Cooperation Council Countries. Lancet Oncol. 2015;16(5):e246–e257. - PubMed
-
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical